Evidence map›Paper›PMID 39170483›Full record

ArticleHeliyon2024

Poly (I:C) increases the expression of

Mehdi Abbaspour, Mehri Ghafourian Boroujerdnia, Mohammad Taher Tahoori, Mojtaba Oraki Kohshour, Mohammad Ghasemi Dehcheshmeh, Sareh Amirzadeh, Afshin Amari

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mehdi AbbaspourDepartment of Immunology, School of Medicine Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Mehri Ghafourian BoroujerdniaDepartment of Immunology, School of Medicine Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Mohammad Taher TahooriDepartment of Immunology, School of Medicine Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Mojtaba Oraki KohshourDepartment of Immunology, School of Medicine Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Mohammad Ghasemi DehcheshmehDepartment of Immunology, School of Medicine Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Sareh AmirzadehDepartment of Infertility, Infertility Research and Treatment Center of ACECR, Ahvaz, Iran.
Afshin AmariDepartment of Immunology, School of Medicine Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mesenchymal stem cells (MSCs) are commonly employed as a powerful tool for the treatment of immune-mediated problems owing to their capacity to regulate the immune system and differentiate into different tissues. Researchers use mesenchymal stem cell products given the limitations associated with the application of MSCs. Exosomes are nanometer vesicles derived from MSCs that are used in cell-free therapy. Inflammatory environmental conditions, such as stimulation of Toll-like receptor 3 (TLR-3), has the ability to adjust the immune-regulating properties and anti-inflammatory function of mesenchymal stem cells and their exosomes. Galectins and hepatocyte growth factor (HGF) are known as immunomodulatory factors in mesenchymal stem cells. This study was designed to examine the expression of Methods: To begin, the explant technique was used to extract mesenchymal stem cells from human umbilical cord Wharton's jelly. Then, the stem cells were stimulated using Poly (I:C) at three time intervals of 12, 24 and 48 h. Exosomes secreted from the supernatant of cells were extracted and exosome confirmation tests, including Scanning electron microscopy (SEM), Dynamic light scattering (DLS) and Flow cytometry were performed. Finally, the expression of Results: The findings of our study indicated that following stimulation with Poly (I:C), the expression of Conclusion: TLR3 stimulation can increase the expression of

Indexed as

ExosomeGalectinHepatocyte growth factorMesenchymal stem cellsToll-like receptor 3

Identifiers

PMID39170483
PMCPMC11336598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.